Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Transcranial Alternating Current Stimulation (tACS) in Aphasia

NCT: NCT04375722 · RECRUITING

NCT IDNCT04375722
StatusRECRUITING
Start Date2020-01-04
Completion2030-12
SponsorMedical College of Wisconsin (OTHER)
First posted
Last updated

Brief Summary

This study will assess the effects of transcranial alternating current stimulation (tACS) on language recovery after stroke as well as healthy language functions.

Frequently Asked Questions

What is Transcranial Alternating Current Stimulation (tACS) in Aphasia?

Transcranial Alternating Current Stimulation (tACS) in Aphasia is a clinical trial registered under NCT04375722. Current status: RECRUITING.

What is the status of NCT04375722?

The current status of NCT04375722 (Transcranial Alternating Current Stimulation (tACS) in Aphasia) is: RECRUITING.

When did Transcranial Alternating Current Stimulation (tACS) in Aphasia start?

Transcranial Alternating Current Stimulation (tACS) in Aphasia started on 2020-01-04.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑